Reply to Letter to the Editor Regarding: “Applying to dermatology residency during the COVID-19 pandemic”

Documenti analoghi

• Applying to dermatology residency during the COVID-19 pandemic
  di: Kearns, Donovan G., et al.
  Pubblicazione: (2020)
• Assessing the risk of dupilumab use for atopic dermatitis during the COVID-19 pandemic
  di: Kearns, Donovan G., et al.
  Pubblicazione: (2020)
• Assessing the risk of adalimumab use for hidradenitis suppurativa during the COVID-19 pandemic
  di: Kearns, Donovan G., et al.
  Pubblicazione: (2020)
• Response to: “Applying to dermatology residency during the COVID-19 pandemic”
  di: Alia, Erisa, et al.
  Pubblicazione: (2021)
• Modifications to dermatology residency education during the COVID-19 pandemic
  di: Mufti, Asfandyar, et al.
  Pubblicazione: (2020)